48例原发性支气管肺癌介入治疗临床分析  

The clinical study of interventional treatment through bronchial artery of 48 cases of primary bronchial pulmonary carcinoma

作　　者：勾素华[1] 李主镜[1] 陈炳祥[1] 

机构地区：[1]深圳市罗湖区人民医院,518001

出　　处：《福建医药杂志》2004年第1期23-24,共2页Fujian Medical Journal

摘　　要：目的 探讨经支气管动脉化疗与血管栓塞治疗对原发性支气管肺癌的治疗效果。方法 对48例经病理证实的肺癌患者行支气管动脉化疗或血管栓塞治疗,每次间隔时间为4～6周。结果 完全缓解14例,部分缓解12例,病灶稳定20例,进展2例。结论 绝大多数支气管肺癌患者经支气管动脉化疗或血管栓塞治疗后取得了良好的疗效。Objective To study the value of interventional treatment through bronchial artery of primary bronchial pulmonary carcinoma. Methods 48 clinically proven cases of pulmonary carcinoma were treated by chemical or embolic methods through bronchial artery and the interval time was between 4～6 weeks. Results 14 cases were completely alleviated, 12 partially alleviated, 20 were steady and 2 were progressive. Conclusions Most cases of pulmonary carcinoma can get favorable effects by interventional treatment through bronchial artery.

关 键 词：原发性支气管肺癌 介入治疗 组织类型 支气管动脉插管 药物灌注 

分 类 号：R734.2[医药卫生—肿瘤] R730.5[医药卫生—临床医学]